ACUTE MYELOID LEUKEMIA RECURRENT
Clinical trials for ACUTE MYELOID LEUKEMIA RECURRENT explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOID LEUKEMIA RECURRENT trials appear
Sign up with your email to follow new studies for ACUTE MYELOID LEUKEMIA RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First patients to receive experimental 'Memory' immune cell therapy for blood cancer
Disease control Recruiting nowThis is a first-in-human study to test the safety of a new type of immune cell therapy for adults with acute myeloid leukemia (AML). Researchers will give patients specially trained 'memory-like' natural killer (NK) cells along with a standard drug called venetoclax, aiming to be…
Matched conditions: ACUTE MYELOID LEUKEMIA RECURRENT
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope for Tough-to-Treat leukemia: experimental drug enters human trials
Disease control Recruiting nowThis study is testing whether adding an experimental drug called ziftomenib to standard leukemia treatments is safe and effective. It will involve 420 adults with acute myeloid leukemia (AML) who have specific genetic changes in their cancer cells. The main goals are to find the …
Matched conditions: ACUTE MYELOID LEUKEMIA RECURRENT
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC